<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Staphylococcus-associated glomerulonephritis in adults</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Staphylococcus-associated glomerulonephritis in adults</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Staphylococcus-associated glomerulonephritis in adults</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Samih H Nasr, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jai Radhakrishnan, MD, MS</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Vivette D D'Agati, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Richard J Glassock, MD, MACP</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Albert Q Lam, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jul 20, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1127798000"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The term postinfectious glomerulonephritis has primarily referred to poststreptococcal glomerulonephritis. This is still appropriate in children, but in adults, as described below, staphylococcus-associated glomerulonephritis (previously referred to as post-staphylococcal glomerulonephritis) may be as or more common.</p><p>This topic will review staphylococcus-associated glomerulonephritis in adults. Other causes of infection-related glomerulonephritis, including poststreptococcal glomerulonephritis and glomerulonephritis associated with endocarditis or with viral, fungal, protozoal, or parasitic infections, are discussed elsewhere:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/6118.html" rel="external">"Poststreptococcal glomerulonephritis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/3054.html" rel="external">"Kidney disease in the setting of infective endocarditis or an infected ventriculoatrial shunt"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/3065.html" rel="external">"Overview of kidney disease associated with hepatitis C virus infection"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/3119.html" rel="external">"Kidney disease associated with hepatitis B virus infection"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/14027.html" rel="external">"Overview of kidney disease in patients with HIV"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/3055.html" rel="external">"Membranoproliferative glomerulonephritis: Classification, clinical features, and diagnosis", section on 'Infections'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/3057.html" rel="external">"Schistosomiasis and glomerular disease"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5669.html" rel="external">"Echinococcosis: Clinical manifestations and diagnosis", section on 'Other organs'</a>.)</p><p></p><p class="headingAnchor" id="H4152383211"><span class="h1">TERMINOLOGY</span><span class="headingEndMark"> — </span>Proposed general terms for glomerulonephritis induced by infections are <strong>infection-associated </strong>or<strong> infection-related glomerulonephritis</strong> [<a href="#rid1">1</a>]. The most commonly used term for streptococcus-related disease is poststreptococcal glomerulonephritis because the kidney disease typically begins <strong>after</strong> the usually pharyngeal or skin infection has either resolved spontaneously or been effectively treated.</p><p>By contrast, most of the other causes of bacterial infection-associated glomerulonephritis, including that due to staphylococcal<em> </em>infection, occur when the patient is still infected. Thus, we prefer the term <strong>staphylococcus-associated glomerulonephritis</strong> to distinguish it from glomerulonephritis that can develop when the infection is no longer active (eg, poststreptococcal glomerulonephritis). (See  <a class="medical medical_review" href="/d/html/6118.html" rel="external">"Poststreptococcal glomerulonephritis"</a>.)</p><p><strong>Immunoglobulin A (IgA)-dominant infection-related glomerulonephritis</strong>, which can occur with staphylococcal infection, is a distinct morphologic variant of infection-related glomerulonephritis characterized by dominant or codominant glomerular deposits of IgA [<a href="#rid2">2-4</a>].</p><p class="headingAnchor" id="H4003753842"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>Staphylococcus-associated glomerulonephritis is an immune complex-mediated disease [<a href="#rid5">5</a>]. The antigen component of the immune complex is derived from the infective agent, similar to poststreptococcal glomerulonephritis. (See  <a class="medical medical_review" href="/d/html/6118.html" rel="external">"Poststreptococcal glomerulonephritis", section on 'Pathogenesis'</a>.)</p><p>The pathogenesis of staphylococcus-associated glomerulonephritis has not been adequately studied, and it remains largely unknown. It likely involves glomerular deposition of preformed circulating immune complexes. It is possible that in situ immune complex formation may occur (as it does in poststreptococcal glomerulonephritis) due to cationic staphylococcal antigens planted in the glomeruli [<a href="#rid6">6-8</a>]. However, glomerular deposition of preformed circulating immune complexes is likely to be a more important pathogenic mechanism in staphylococcus-associated glomerulonephritis, because in staphylococcus-associated glomerulonephritis, the circulating antigens and the antibodies directed against these antigens coexist in the circulation for prolonged periods of time [<a href="#rid5">5</a>]. With this prolonged antigenemia, there is a greater opportunity for immune complexes to form in the circulation, which then deposit causing glomerulonephritis and, in some cases, cutaneous vasculitis.</p><p>Staphylococcus-associated glomerulonephritis requires continued antigen production, and therefore continued active (and usually prolonged) infection, to perpetuate the kidney inflammation. If the infection is effectively treated, the activity of the glomerulonephritis should eventually abate. This same paradigm applies to glomerulonephritis due to other non-streptococcal bacteria, viral infections such as hepatitis B and C, and parasitic infections.</p><p>Staphylococcal antigens may act as super antigens, activating T cells, which results in polyclonal B cell activation and production of polyclonal IgA, immunoglobulin G (IgG), and immunoglobulin M (IgM) [<a href="#rid9">9,10</a>]. Some of these antibodies, often IgA, react with staphylococcal antigens [<a href="#rid11">11,12</a>]. This may explain, in part, why glomerular immune deposits in patients with staphylococcus-associated glomerulonephritis usually show heavy IgA deposits that are dominant or codominant with IgG. In this respect, staphylococcus-associated glomerulonephritis is distinct from poststreptococcal glomerulonephritis but can be misdiagnosed as primary IgA nephropathy. (See <a class="local">'Differential diagnosis'</a> below.)</p><p class="headingAnchor" id="H944973866"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Staphylococcus-associated glomerulonephritis is uncommon (less than 1 percent of kidney biopsies) and primarily occurs in middle-aged or older adult patients [<a href="#rid2">2,6,13-17</a>]. In older adult patients in resource-abundant countries, glomerulonephritis due to bacterial infection may be more often due to <em>Staphylococcus</em> than group A beta-hemolytic <em>Streptococcus</em>. This may not be the case in resource-limited countries. As an example, in a series of 501 adult patients with bacterial infection-related glomerulonephritis from the Indian subcontinent (mean age 40 years), the organism was isolated in 226 of 353 (64 percent) patients with available data, and among them the responsible organism was streptococcus in 61 percent, <em>Escherichia coli</em> in 14 percent, and staphylococcus in 11 percent [<a href="#rid18">18</a>]. In addition, many affected adults have a predisposition to staphylococcal infection such as diabetes, alcoholism, cancer, or intravenous drug addiction.</p><p class="headingAnchor" id="H3136359124"><span class="h1">CLINICAL MANIFESTATIONS</span><span class="headingEndMark"> — </span>Adults with staphylococcus-associated glomerulonephritis usually present with a <strong>concurrent infection</strong> and frequently with hematuria, proteinuria of varying degrees, a rising serum creatinine, and/or edema. The most common manifestations are summarized below.</p><p class="headingAnchor" id="H298112217"><span class="h2">Findings at presentation</span><span class="headingEndMark"> — </span>The clinical manifestations of staphylococcus-associated glomerulonephritis are similar to those in other causes of glomerulonephritis. (See  <a class="medical medical_review" href="/d/html/3041.html" rel="external">"Glomerular disease: Evaluation and differential diagnosis in adults"</a>.)</p><p>In studies of patients with staphylococcus-associated glomerulonephritis (which also included patients with glomerulonephritis due to other bacteria), the following findings have been noted [<a href="#rid13">13-15</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Peripheral edema was present in approximately 50 percent of patients, and new-onset hypertension was present in 12 to 29 percent, with other patients (31 percent in one of the studies) having a history of underlying hypertension [<a href="#rid13">13</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The urine sediment revealed hematuria in almost all patients with or without leukocyturia and red cell casts. The degree of proteinuria was variable, with 22 to 35 percent having overt nephrotic syndrome.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>New-onset or exacerbated heart failure is not uncommon in older adult patients due to the higher prevalence of underlying cardiovascular disease and the reduced ability to handle the salt and water retention associated with glomerulonephritis [<a href="#rid15">15,19</a>]. In the series of 109 older adult patients, new heart failure was noted in 26 percent of patients overall and in 30 percent of the subset of patients with staphylococcal infection [<a href="#rid15">15</a>].</p><p></p><p>Patients with staphylococcus-associated glomerulonephritis, particularly older adult patients, usually have a diagnosed concurrent staphylococcal infection, although the infection may be undiagnosed in some patients (cultures may be negative, at least initially). This contrasts with poststreptococcal glomerulonephritis, in which the infection is resolved by the time the glomerulonephritis is discovered. As an example, in the study of older adult patients cited above, the clinical diagnosis of staphylococcal infection coincided with the first clinical recognition of glomerulonephritis in 43 percent of patients [<a href="#rid15">15</a>]. The median time from clinical diagnosis of staphylococcal infection to diagnosis of kidney disease was one week (range 0 to 12 weeks), which varied with the site of infection: zero weeks for heart and bone infections and one week for skin and lung infections.</p><p>Cutaneous vasculitis can occur in patients with staphylococcus-associated glomerulonephritis, imitating IgA vasculitis (Henoch-Schönlein purpura) or antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis [<a href="#rid2">2,20,21</a>].</p><p class="headingAnchor" id="H2792699648"><span class="h2">Most common sites of infection</span><span class="headingEndMark"> — </span>The site of infection is varied in adults with staphylococcal infection [<a href="#rid1">1</a>]. In a study of 78 patients with staphylococcus-associated glomerulonephritis, the most common sites of infection were [<a href="#rid2">2</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Heart/endocarditis – 18 patients (23 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Skin, including leg ulcers and cellulitis – 17 patients (22 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Bone/osteomyelitis – 17 patients (22 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Lung/pneumonia – 6 patients (8 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Visceral abscess – 6 patients (8 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Urinary tract infection – 2 patients (6 percent)</p><p></p><p class="headingAnchor" id="H2071543761"><span class="h2">Laboratory findings</span><span class="headingEndMark"> — </span>The laboratory findings at the time of presentation are similar to those in other forms of glomerulonephritis. (See  <a class="medical medical_review" href="/d/html/3041.html" rel="external">"Glomerular disease: Evaluation and differential diagnosis in adults"</a>.)</p><p>In one study of older adult patients, the laboratory findings in 50 patients with staphylococcus-associated glomerulonephritis were as follows [<a href="#rid15">15</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Hematuria – 98 percent (15 percent macroscopic)</p><p class="bulletIndent1"><span class="glyph">●</span>Leukocyturia – 65 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Mean protein excretion – 3 g/day (21 percent had all features of the nephrotic syndrome)</p><p class="bulletIndent1"><span class="glyph">●</span>Mean serum creatinine at the time of biopsy – 5.1 mg/dL (451 micromol/L)</p><p></p><p>Patients with staphylococcus-associated glomerulonephritis commonly but not universally have hypocomplementemia. As an example, 39 of the 50 patients with staphylococcus-associated glomerulonephritis included in the study of older adult patients cited above had testing for serum complement [<a href="#rid15">15</a>]. Of these 39 patients, 82 percent had hypocomplementemia (low C3 with normal C4 in 56 percent, low C3 and C4 in 41 percent, and low C4 with normal C3 in 3 percent). In addition, positive serologic testing for ANCA can be observed in 25 to 30 percent of patients with staphylococcus-associated glomerulonephritis [<a href="#rid2">2,22</a>]. A peptide of plasmid-encoded 6-phosphogluconate dehydrogenase, present in some <em>Staphylococcus aureus</em> strains, induces anti-myeloperoxidase autoimmunity in mice, and this peptide is immunogenic in humans [<a href="#rid23">23</a>]. This could explain the development of ANCA autoimmunity in some patients with staphylococcus-associated glomerulonephritis.</p><p>Other causes of glomerulonephritis that are associated with hypocomplementemia are mentioned below. (See <a class="local">'Serologic testing'</a> below.)</p><p class="headingAnchor" id="H2066520337"><span class="h3">Bacterial cultures</span><span class="headingEndMark"> — </span>In contrast to poststreptococcal glomerulonephritis, there are <strong>no</strong> serologic tests to detect staphylococcal infection. Thus, an inciting staphylococcal infection can only be identified from a positive culture. Most cases of staphylococcus-associated glomerulonephritis are caused by <em>S. aureus,</em> with a higher incidence of methicillin-resistant <em>S. aureus</em> than methicillin-sensitive <em>S. aureus, </em>although coagulase-negative staphylococcus species including <em>S. epidermidis</em> and <em>S. hemolyticus</em> can rarely cause the disease [<a href="#rid2">2,15</a>]. <em>S. epidermidis</em> is the most commonly reported organism causing shunt nephritis [<a href="#rid24">24</a>]. (See  <a class="medical medical_review" href="/d/html/3054.html" rel="external">"Kidney disease in the setting of infective endocarditis or an infected ventriculoatrial shunt"</a>.) </p><p>In some patients, an infectious agent cannot be identified [<a href="#rid1">1,6,13-15,25</a>], and suspicion of staphylococcus-associated glomerulonephritis is based upon a probable infection. If there is no clear history of infection, then the main clinical clue other than kidney biopsy is hypocomplementemia, which is present in many but not all patients. However, hypocomplementemia also occurs in a number of other causes of glomerulonephritis. (See <a class="local">'Serologic testing'</a> below.)</p><p class="headingAnchor" id="H1875735194"><span class="h1">EVALUATION AND DIAGNOSIS</span></p><p class="headingAnchor" id="H2229716147"><span class="h2">When to suspect the diagnosis</span><span class="headingEndMark"> — </span>The presence of staphylococcus-associated glomerulonephritis should be suspected in patients with clinical manifestations of active glomerulonephritis (eg, hematuria with or without red cell casts, often accompanied by proteinuria and an elevation in serum creatinine) in conjunction with a known or suspected recent or concurrent staphylococcal infection.</p><p class="headingAnchor" id="H3365922263"><span class="h2">Diagnostic evaluation</span></p><p class="headingAnchor" id="H3404237622"><span class="h3">Serologic testing</span><span class="headingEndMark"> — </span>In patients with suspected staphylococcus-associated glomerulonephritis, we obtain the following serologic tests to evaluate for other potential causes of glomerulonephritis:</p><p class="bulletIndent1"><span class="glyph">●</span>Serum C3 and C4 complement levels</p><p class="bulletIndent1"><span class="glyph">●</span>Antinuclear antibody (ANA)</p><p class="bulletIndent1"><span class="glyph">●</span>Anti-double-stranded DNA (anti-dsDNA) antibody</p><p class="bulletIndent1"><span class="glyph">●</span>Antineutrophil cytoplasmic autoantibodies (ANCA)</p><p class="bulletIndent1"><span class="glyph">●</span>Anti-glomerular basement membrane (anti-GBM) antibodies</p><p class="bulletIndent1"><span class="glyph">●</span>Serology for hepatitis C virus, hepatitis B virus, and HIV</p><p class="bulletIndent1"><span class="glyph">●</span>Serum cryoglobulins</p><p class="bulletIndent1"><span class="glyph">●</span>Serum free light chains and serum protein electrophoresis with immunofixation</p><p></p><p>As noted above, patients with staphylococcus-associated glomerulonephritis often have hypocomplementemia. As examples, low C3 and C4 are not characteristic of IgA nephropathy, ANCA-associated vasculitis, or anti-GBM disease. However, hypocomplementemia is absent in some patients with staphylococcus-associated glomerulonephritis, and hypocomplementemia combined with an active urine sediment can be seen with other diseases, such as lupus nephritis, C3 glomerulonephritis, mixed cryoglobulinemia, and in infrequent patients with atheroembolic disease involving the kidney who have an active urine sediment. (See  <a class="medical medical_review" href="/d/html/3041.html" rel="external">"Glomerular disease: Evaluation and differential diagnosis in adults"</a>.)</p><p>The pattern of hypocomplementemia may sometimes help distinguish staphylococcus-associated or other bacterial causes of glomerulonephritis, in which the typical pattern is low C3 and normal C4 levels, from these other disorders [<a href="#rid6">6</a>]. As examples, lupus nephritis is usually associated with reduced levels of both C3 and C4, and mixed cryoglobulinemia is frequently characterized by low C4 and normal C3. However, there is overlap, as approximately one-third of patients with bacterial infection-related glomerulonephritis have low C3 and C4; in addition, a positive ANA may be seen with shunt nephritis due to staphylococcal infection [<a href="#rid6">6</a>].</p><p>Up to 22 percent of patients with staphylococcus-associated glomerulonephritis, with or without crescents on biopsy, are positive for ANCA [<a href="#rid2">2</a>]. The majority of these patients have infectious endocarditis and antibodies against proteinase 3 (PR3) [<a href="#rid2">2</a>].</p><p>The general evaluation of glomerulonephritis is discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/3041.html" rel="external">"Glomerular disease: Evaluation and differential diagnosis in adults", section on 'Evaluation of glomerulonephritis'</a>.)</p><p class="headingAnchor" id="H3112220005"><span class="h3">Kidney biopsy</span><span class="headingEndMark"> — </span>We suggest that a kidney biopsy be performed in most adults suspected of having staphylococcus-associated glomerulonephritis after bacteremia has resolved. However, a kidney biopsy may <strong>not </strong>be required if <strong>all three</strong> of the following criteria are satisfied:</p><p class="bulletIndent1"><span class="glyph">●</span>There is clear evidence of overt glomerulonephritis, marked by glomerular hematuria, heavy proteinuria (greater than 1 g/day), and an abnormally elevated serum creatinine. (See  <a class="medical medical_review" href="/d/html/7208.html" rel="external">"Etiology and evaluation of hematuria in adults", section on 'Glomerular versus nonglomerular bleeding'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A serious infection is present, and <em>Staphylococcus aureus</em> is documented by a positive blood culture (ideally two positive blood cultures, each from a different site), wound culture, or tissue culture (eg, bone biopsy of suspected osteomyelitis). (See <a class="local">'Most common sites of infection'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The staphylococcal infection is concurrent with the development of the glomerulonephritis.</p><p></p><p>Even if all three of the above criteria are met, we still suggest obtaining a kidney biopsy if there is laboratory evidence suggestive of an alternative diagnosis. (See <a class="local">'Serologic testing'</a> above.) </p><p class="headingAnchor" id="H1391381066"><span class="h4">Histologic findings</span><span class="headingEndMark"> — </span>The characteristic histologic findings in staphylococcus-associated glomerulonephritis include the following:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Light microscopy</strong> – The most common histologic pattern of injury on light microscopy is diffuse endocapillary proliferative and exudative glomerulonephritis with more than 50 percent of glomeruli showing occlusion of the peripheral capillaries by endocapillary hypercellularity, including abundant intracapillary infiltrating neutrophils [<a href="#rid13">13,15</a>]. Less common histologic patterns include focal proliferative and mesangial proliferative glomerulonephritis, crescentic and/or necrotizing glomerulonephritis (defined by the presence of crescents and/or necrosis in at least 50 percent of glomeruli), and membranoproliferative glomerulonephritis (MPGN). Tubulointerstitial changes commonly accompany the glomerulonephritis and include red blood cell casts and varying degrees of acute tubular injury, interstitial inflammation, and interstitial edema.</p><p></p><p class="bulletIndent1">The site of infection may impact on the glomerular findings. As an example, a crescentic and necrotizing pattern is the most common finding in patients with glomerulonephritis associated with infective endocarditis [<a href="#rid22">22,26,27</a>], and MPGN is the most common pattern in patients with glomerulonephritis associated with an infected ventriculoatrial shunt (also called shunt nephritis) [<a href="#rid28">28,29</a>]. (See  <a class="medical medical_review" href="/d/html/3054.html" rel="external">"Kidney disease in the setting of infective endocarditis or an infected ventriculoatrial shunt", section on 'Clinical features and kidney biopsy findings'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Immunofluorescence microscopy</strong> – Immunofluorescence microscopy typically reveals C3 dominant or codominant (with IgA or IgG) glomerular staining  (<a class="graphic graphic_picture graphicRef63432" href="/d/graphic/63432.html" rel="external">picture 1</a>). In most cases, there is coarsely granular mesangial and glomerular wall staining, resembling the "starry sky pattern," while a minority exhibit predominantly glomerular capillary wall positivity ("garland pattern") or predominantly mesangial staining ("mesangial pattern") [<a href="#rid13">13,15,30</a>].</p><p></p><p class="bulletIndent1">C3 can be the only immunoreactant detected by immunofluorescence (seen in 27 percent of patients with staphylococcus-associated glomerulonephritis in a study of older adult patients [<a href="#rid15">15</a>]), but more often there is co-deposition of one or more immunoglobulins and/or C1q. Patients with staphylococcus-associated glomerulonephritis often have IgA-dominant disease  (<a class="graphic graphic_picture graphicRef73422" href="/d/graphic/73422.html" rel="external">picture 2</a>) [<a href="#rid3">3,6,15</a>]. In one study, IgA staining was trace in 25 percent of biopsies, mild in 19 percent, moderate in 44 percent, and strong in 12 percent [<a href="#rid2">2</a>]. IgA dominance in patients with bacterial infection-related glomerulonephritis appears to occur mainly in association with staphylococcal infection, which is in contrast to the predominant IgG deposition in poststreptococcal glomerulonephritis [<a href="#rid3">3,4,6,13,15,16,20,31,32</a>].</p><p></p><p class="bulletIndent1">In patients who have C3 deposition with no significant immunoglobulin deposition, staphylococcus-associated glomerulonephritis may be difficult to distinguish from C3 glomerulonephritis. Helpful distinguishing histologic and clinical features are discussed below. (See <a class="local">'Distinction from C3 glomerulonephritis'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Electron microscopy</strong> – Electron microscopy typically shows large, hump-shaped subepithelial electron dense deposits  (<a class="graphic graphic_picture graphicRef76739" href="/d/graphic/76739.html" rel="external">picture 3</a>). In resolving disease, the humps are preferentially located overlying the glomerular basement membrane reflection over the mesangium.</p><p></p><p class="bulletIndent1">Humps are not specific for staphylococcus-associated glomerulonephritis as they are also common in C3 glomerulonephritis and dense deposit disease. Small mesangial, subendothelial, and/or intramembranous deposits are not infrequent in adults with staphylococcus-associated glomerulonephritis.</p><p></p><p class="headingAnchor" id="H4071281172"><span class="h2">Establishing the diagnosis</span><span class="headingEndMark"> — </span>In most adults, a <strong>presumptive </strong>diagnosis can be made in patients with <strong>at least two</strong> of the following criteria:</p><p class="bulletIndent1"><span class="glyph">●</span>Hypocomplementemia (primarily low C3).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Endocapillary proliferation and exudative glomerulonephritis on light microscopy  (<a class="graphic graphic_picture graphicRef51688" href="/d/graphic/51688.html" rel="external">picture 4</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>C3 dominant or codominant glomerular staining on immunofluorescence microscopy  (<a class="graphic graphic_picture graphicRef63432" href="/d/graphic/63432.html" rel="external">picture 1</a>). However, many if not most patients with staphylococcus-associated glomerulonephritis have IgA-dominant or codominant disease (together with intense C3 staining). </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hump-shaped subepithelial deposits on electron microscopy  (<a class="graphic graphic_picture graphicRef76739" href="/d/graphic/76739.html" rel="external">picture 3</a>).</p><p></p><p>However, hypocomplementemia and these pathologic findings are <strong>not</strong> completely specific for glomerulonephritis due to a bacterial infection. Thus, a <strong>confirmed</strong> diagnosis of staphylococcus-associated glomerulonephritis requires that the disease activity (eg, hematuria, hypocomplementemia if present) abate after successful eradication of the infection, although there may be persistent elevation of the serum creatinine and proteinuria reflecting irreversible kidney injury.</p><p class="headingAnchor" id="H231125477"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>In adults who present with acute glomerulonephritis, the differential diagnosis is broad; however, components of the diagnostic evaluation can help to differentiate staphylococcus-associated glomerulonephritis from most other causes of glomerulonephritis. (See <a class="local">'Diagnostic evaluation'</a> above.)</p><p>Nevertheless, there are three other glomerulonephritides that are more challenging to distinguish from staphylococcus-associated glomerulonephritis. These are discussed below.</p><p class="headingAnchor" id="H3649070477"><span class="h2">Distinction from C3 glomerulonephritis</span><span class="headingEndMark"> — </span>In patients who have C3 deposition with no significant immunoglobulin deposition on immunofluorescence microscopy, staphylococcus-associated glomerulonephritis may be difficult to distinguish from C3 glomerulonephritis.</p><p>The following clinical features can help distinguish between these two disorders (see  <a class="medical medical_review" href="/d/html/3055.html" rel="external">"Membranoproliferative glomerulonephritis: Classification, clinical features, and diagnosis", section on 'C3 glomerulonephritis'</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Hematuria can occur within a few days after an upper respiratory infection in patients with C3 glomerulonephritis [<a href="#rid33">33</a>], an association that has not been reported with staphylococcal infection.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Persistent or recurrent active glomerulonephritis over a prolonged period is common in C3 glomerulonephritis. Furthermore, depression of C3 usually persists in C3 glomerulonephritis. This is in contrast to the typical resolution of active disease and normalization of complement levels in staphylococcus-associated glomerulonephritis, although signs of irreversible injury during the acute episode may persist, such as an elevated serum creatinine and/or proteinuria. (See  <a class="medical medical_review" href="/d/html/3055.html" rel="external">"Membranoproliferative glomerulonephritis: Classification, clinical features, and diagnosis", section on 'C3 glomerulonephritis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The presence of membranoproliferative glomerulonephritis (MPGN) on kidney biopsy and prolonged hypocomplementemia, a pattern not typically seen with staphylococcus-associated glomerulonephritis.</p><p></p><p class="bulletIndent1">Pathologic findings on immunofluorescence and electron microscopy may also be helpful:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Immunofluorescence microscopy in C3 glomerulonephritis typically reveals intense C3 glomerular staining without IgG deposition and minimal or no staining for other immunoreactants. C3 deposition also occurs in staphylococcus-related glomerulonephritis  (<a class="graphic graphic_picture graphicRef63432" href="/d/graphic/63432.html" rel="external">picture 1</a>), but it is usually accompanied by immunoglobulin deposition which, as noted above, is in some cases IgA dominant  (<a class="graphic graphic_picture graphicRef73422" href="/d/graphic/73422.html" rel="external">picture 2</a>). (See <a class="local">'Histologic findings'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Electron microscopy in C3 glomerulonephritis typically reveals both mesangial deposits and capillary wall deposits in subendothelial, intramembranous, and/or subepithelial locations  (<a class="graphic graphic_picture graphicRef50927" href="/d/graphic/50927.html" rel="external">picture 5</a>). The finding of large mesangial, subendothelial, and/or intramembranous deposits should favor C3 glomerulonephritis over staphylococcus-associated glomerulonephritis. By contrast, a preferential localization of subepithelial deposits on the glomerular basement membrane reflection over the mesangium and evidence of resorption within the deposits favor staphylococcus-associated glomerulonephritis [<a href="#rid6">6</a>]. (See <a class="local">'Histologic findings'</a> above.)</p><p></p><p class="headingAnchor" id="H303126065"><span class="h2">Distinction from IgA nephropathy</span><span class="headingEndMark"> — </span>IgA-dominant staphylococcus-associated glomerulonephritis can be difficult to distinguish from primary IgA nephropathy that is triggered or reactivated by infection. (See  <a class="medical medical_review" href="/d/html/3112.html" rel="external">"IgA nephropathy: Clinical features and diagnosis"</a>.)</p><p>The following clinical and pathologic features suggest a diagnosis of staphylococcus-associated glomerulonephritis rather than primary IgA nephropathy:</p><p class="bulletIndent1"><span class="glyph">●</span>Initial presentation at an older age or in a patient with diabetes.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Acute kidney injury at the time of initial presentation, which can also occur in IgA nephropathy when there is gross hematuria. (See  <a class="medical medical_review" href="/d/html/3039.html" rel="external">"IgA nephropathy: Treatment and prognosis"</a> and  <a class="medical medical_review" href="/d/html/3112.html" rel="external">"IgA nephropathy: Clinical features and diagnosis", section on 'Clinical features'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hypocomplementemia, which is not typically seen in IgA nephropathy.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Diffuse exudative glomerulonephritis on light microscopy  (<a class="graphic graphic_picture graphicRef51688" href="/d/graphic/51688.html" rel="external">picture 4</a>) rather than the typical mesangial proliferative disease in IgA nephropathy  (<a class="graphic graphic_picture graphicRef62380" href="/d/graphic/62380.html" rel="external">picture 6</a>). By contrast, the presence of segmentally sclerosed (scarred) glomeruli favors IgA nephropathy [<a href="#rid34">34</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Stronger intensity of immunofluorescence staining for C3 than IgA in the glomerular deposits  (<a class="graphic graphic_picture graphicRef63432" href="/d/graphic/63432.html" rel="external">picture 1</a>) rather than the predominant global mesangial IgA staining in IgA nephropathy  (<a class="graphic graphic_picture graphicRef69895" href="/d/graphic/69895.html" rel="external">picture 7</a>). On the other hand, IgA staining of sclerosed glomeruli favors IgA nephropathy [<a href="#rid34">34</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Subepithelial humps on electron microscopy  (<a class="graphic graphic_picture graphicRef76739" href="/d/graphic/76739.html" rel="external">picture 3</a>) rather than mesangial deposits in IgA nephropathy  (<a class="graphic graphic_picture graphicRef58102" href="/d/graphic/58102.html" rel="external">picture 8</a>).</p><p></p><p>Rarely, patients with IgA-dominant staphylococcus-associated glomerulonephritis develop a vasculitic skin rash (with or without IgA deposition in the small vessels of skin), mimicking IgA vasculitis [<a href="#rid21">21</a>]. Conversely, there are anecdotal reports of IgA vasculitis in adults associated with staphylococcal infection [<a href="#rid35">35,36</a>]. A presentation with acute kidney injury, hypocomplementemia, a stronger intensity of immunofluorescence staining for C3 than IgA in the glomerular deposits, and the presence of numerous subepithelial humps on electron microscopy favor IgA-dominant staphylococcus-associated glomerulonephritis over IgA vasculitis. (See  <a class="medical medical_review" href="/d/html/6406.html" rel="external">"IgA vasculitis (Henoch-Schönlein purpura): Clinical manifestations and diagnosis"</a>.)</p><p>A mass spectrometry-based exploratory study comparing staphylococcus-associated glomerulonephritis with IgA nephropathy and normal controls found the glomerular proteomes of staphylococcus-associated glomerulonephritis and IgA nephropathy to be very similar, except for significantly higher levels of monocyte/macrophage proteins (mainly lysozymes and S100A9) in staphylococcus-associated glomerulonephritis (consistent with the higher frequency and severity of endocapillary hypercellularity in this disease compared with primary IgA nephropathy). However, this study did not identify disease-specific biomarkers [<a href="#rid37">37</a>]. </p><p class="headingAnchor" id="H4090717289"><span class="h2">Distinction from poststreptococcal glomerulonephritis</span><span class="headingEndMark"> — </span>Staphylococcus-associated glomerulonephritis differs from poststreptococcal glomerulonephritis in several important ways:</p><p class="bulletIndent1"><span class="glyph">●</span>Poststreptococcal glomerulonephritis is predominantly a childhood disease, whereas staphylococcus-associated glomerulonephritis, with rare exceptions [<a href="#rid25">25,38</a>], is a disease of adults, particularly older adults.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>As previously stated, in contrast to poststreptococcal glomerulonephritis in which the kidney disease typically manifests a few weeks after resolution of infection, staphylococcus-associated glomerulonephritis usually occurs when the patient is still infected.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The site of infection can be variable (eg, skin, soft tissue, heart, indwelling catheter, empyema, etc). Unlike poststreptococcal glomerulonephritis, upper respiratory tract infection is <strong>not</strong> usually a cause of staphylococcus-associated glomerulonephritis. (See <a class="local">'Most common sites of infection'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The kidney prognosis is much worse than in poststreptococcal glomerulonephritis, particularly in patients with underlying diabetic nephropathy. (See <a class="local">'Prognosis'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cutaneous vasculitis can occur in patients with staphylococcus-associated glomerulonephritis [<a href="#rid2">2,20,21</a>]. By contrast, cutaneous vasculitis is not a manifestation of poststreptococcal glomerulonephritis.</p><p></p><p class="headingAnchor" id="H1863159450"><span class="h1">TREATMENT</span><span class="headingEndMark"> — </span>Treatment of staphylococcus-associated glomerulonephritis in adults should focus on eradicating the infection, relieving symptoms, and controlling hypertension and edema. We do <strong>not</strong> use immunosuppressive therapy in such patients.</p><p class="headingAnchor" id="H2379729776"><span class="h2">Eradicate the infection</span><span class="headingEndMark"> — </span>Active infection should be eradicated with appropriate antibiotics, and if needed, surgery should be performed [<a href="#rid5">5,6,13-15</a>]. (See  <a class="medical medical_review" href="/d/html/2134.html" rel="external">"Clinical approach to Staphylococcus aureus bacteremia in adults", section on 'Management'</a>.)</p><p class="headingAnchor" id="H873581403"><span class="h2">Control hypertension and edema</span><span class="headingEndMark"> — </span>Antihypertensive drugs, diuretics, and dietary salt restriction are often necessary in the acute setting to control hypertension and edema. Hypertension in patients with staphylococcus-associated glomerulonephritis (and in most other causes of acute glomerulonephritis) is primarily due to fluid retention, which also is responsible for edema formation. As a result, dietary salt restriction and diuretics, often beginning with loop diuretics, are a reasonable first-line therapy. The goals of diuretic therapy are to control both the hypertension and, if present, edema. (See  <a class="medical medical_review" href="/d/html/3872.html" rel="external">"Overview of hypertension in acute and chronic kidney disease", section on 'Acute glomerular disease'</a> and  <a class="medical medical_review" href="/d/html/3872.html" rel="external">"Overview of hypertension in acute and chronic kidney disease", section on 'Treatment of hypertension in acute glomerular or vascular disease'</a> and  <a class="medical medical_review" href="/d/html/3872.html" rel="external">"Overview of hypertension in acute and chronic kidney disease", section on 'Use of diuretics and goal of therapy'</a>.)</p><p>If hypertension cannot be controlled in the acute setting with salt restriction and diuretics alone, adding an inhibitor of the renin-angiotensin system (eg, angiotensin-converting enzyme [ACE] inhibitor or angiotensin receptor blocker [ARB]) is a reasonable approach, since salt restriction and diuretics tend to increase the activity of the renin-angiotensin system, which will increase the antihypertensive response to angiotensin inhibition. In a series of 501 patients with adult bacterial infection-related glomerulonephritis from the Indian subcontinent (in which most cases were due to streptoccocal infection), the use of renin-angiotensin system blockade was associated with greater kidney survival [<a href="#rid18">18</a>]. (See  <a class="medical medical_review" href="/d/html/3872.html" rel="external">"Overview of hypertension in acute and chronic kidney disease", section on 'Treatment of hypertension in acute glomerular or vascular disease'</a>.)</p><p>If residual kidney disease persists after the acute glomerulonephritis has resolved (ie, chronic kidney disease), then inhibitors of the renin-angiotensin system are first-line antihypertensive drugs in such patients, particularly in patients with persistent proteinuria above 1000 mg/day. These issues are discussed separately. (See  <a class="medical medical_review" href="/d/html/7169.html" rel="external">"Antihypertensive therapy and progression of nondiabetic chronic kidney disease in adults", section on 'Effect of renin-angiotensin system inhibitors on progression of CKD'</a>.)</p><p class="headingAnchor" id="H3072521956"><span class="h2">Do not use immunosuppressive therapy</span><span class="headingEndMark"> — </span>We do not treat patients with staphylococcus-associated glomerulonephritis with immunosuppressive therapy. Immunosuppressive therapy in this setting is not well studied, and there is no clear evidence of benefit. In addition, in patients with active infection, as is often the case in patients with glomerulonephritis due to <em>Staphylococcus</em>, giving high-dose glucocorticoids may potentially lead to clinical worsening or even death [<a href="#rid1">1,5,39-41</a>]. Furthermore, glucocorticoids could lead to dysglycemia. In the above mentioned study from India, 12 percent of patients treated with glucocorticoids developed dysglycemia compared with none of the patients not receiving glucocorticoid therapy [<a href="#rid18">18</a>].</p><p>Data are limited on the efficacy of immunosuppressive therapy in adults with staphylococcus-associated glomerulonephritis. There are no randomized trials. In a retrospective study of 109 older adult patients with bacterial infection-associated glomerulonephritis, 46 percent of whom had staphylococcus-associated glomerulonephritis [<a href="#rid15">15</a>], 22 were treated with glucocorticoids for variable periods of time. The indication for glucocorticoid therapy was an elevated serum creatinine with or without crescents. Three patients had a complete remission, 12 had a persistent elevation in serum creatinine, seven progressed to end-stage kidney disease (ESKD), and four died. There was <strong>no</strong> correlation between glucocorticoid therapy and kidney outcomes. Lack of benefit has also been noted in other observational studies of patients with bacterial infection-related glomerulonephritis, including staphylococcus-associated glomerulonephritis [<a href="#rid6">6,13,14,42</a>].</p><p class="headingAnchor" id="H2911953485"><span class="h1">MONITORING THE CLINICAL COURSE</span><span class="headingEndMark"> — </span>Patients with presumptive staphylococcus-associated glomerulonephritis should be monitored for signs of resolution of active disease, including elimination of active infection, remission of hematuria, reduction in serum creatinine toward the previous baseline value, reduction in proteinuria, and if present, resolution of hypocomplementemia. There are no data on the optimal timing of monitoring these parameters. We suggest the following approach in patients without rapidly progressive crescentic glomerulonephritis (who require more intensive monitoring):</p><p class="bulletIndent1"><span class="glyph">●</span>Urine protein-to-creatinine ratio (UPCR) and measurement of serum creatinine weekly for at least four weeks until the serum creatinine returns to baseline (if known) or is stable.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Microscopic hematuria may take months to completely resolve. Thus, if the serum creatinine returns to baseline or becomes stable, we repeat the urine dipstick analysis at one- to two-month intervals until hematuria has disappeared.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Proteinuria typically resolves more slowly than hematuria, and proteinuria can persist for many months [<a href="#rid6">6</a>]. We follow the UPCR every one to three months for one year.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If hypocomplementemia was present initially, we measure C3 levels at one-month intervals. If the glomerulonephritis is infection related, hypocomplementemia should resolve within two months of appropriate antibiotic therapy.</p><p></p><p>In adults with staphylococcus-associated glomerulonephritis, successful eradication of the infection should result in resolution of the glomerulonephritis. However, many patients do not have complete resolution of the serum creatinine to their prior baseline and will also have persistent proteinuria. The persistent proteinuria and/or an elevated serum creatinine concentration in such patients is thought to represent irreversible scarring with inactive and sclerosing glomerular lesions [<a href="#rid14">14</a>]. In this setting, monitoring of the serum creatinine and UPCR can be performed less frequently, and a repeat kidney biopsy is usually <strong>not</strong> warranted in the absence of an active urine sediment or persistent hypocomplementemia. A possible exception to this general recommendation may occur in patients in whom the initial kidney biopsy suggested that C3 glomerulonephritis might be present rather than staphylococcus-associated glomerulonephritis, although this is much more of an issue with streptococcal infection.</p><p>Persistent or recurrent staphylococcus-associated glomerulonephritis is uncommon and should suggest an alternate diagnosis such as C3 glomerulonephritis. Persistent disease can occur with persistent staphylococcal infections, as may be seen with an infected ventriculoatrial shunt, leading to what has been called shunt nephritis (see  <a class="medical medical_review" href="/d/html/3054.html" rel="external">"Kidney disease in the setting of infective endocarditis or an infected ventriculoatrial shunt", section on 'Clinical features and kidney biopsy findings'</a>). Recurrent glomerulonephritis has been reported in patients with recurrent or new infection [<a href="#rid14">14</a>].</p><p class="headingAnchor" id="H1963835019"><span class="h1">PROGNOSIS</span><span class="headingEndMark"> — </span>The long-term kidney outcomes in patients with bacterial infection-associated glomerulonephritis (ie, not specifically staphylococcus-associated glomerulonephritis) were evaluated in a study of 86 adults in which 48 had at least three months of follow-up; four patients who had attained complete remission in less than three months were also included [<a href="#rid13">13</a>]. At a mean follow-up of 25 months, the following findings were noted:</p><p class="bulletIndent1"><span class="glyph">●</span>Among the 41 patients without underlying diabetic nephropathy, 23 (56 percent) attained complete remission, 11 (27 percent) had persistent kidney function impairment, and 7 (17 percent) progressed to end-stage kidney disease (ESKD) requiring kidney replacement therapy.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Among the 11 patients with underlying diabetic nephropathy, most of whom had staphylococcus-associated glomerulonephritis, two (18 percent) had persistent kidney function impairment, and nine (82 percent) progressed to ESKD. Similarly poor kidney outcomes in patients with underlying diabetic nephropathy have been reported in other studies [<a href="#rid42">42</a>].</p><p></p><p>The kidney prognosis also appears to be worse in older patients [<a href="#rid15">15,25,42</a>]. In one series of 109 older adult patients (age 65 years or more), 34 patients with staphylococcus-associated glomerulonephritis had three months or more of follow-up [<a href="#rid15">15</a>]. Among these patients, eight (24 percent) had complete recovery of kidney function, 11 (32 percent) had persistent kidney function impairment, and 15 (44 percent) progressed to ESKD, 11 of whom required dialysis at the time of kidney biopsy. Other risk factors for the development of ESKD included the presence of diabetic nephropathy and a higher degree of tubular atrophy and interstitial fibrosis on kidney biopsy, which are markers of chronic disease.</p><p class="headingAnchor" id="H156514170"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/110250.html" rel="external">"Society guideline links: Glomerular disease in adults"</a>.)</p><p class="headingAnchor" id="H1127800794"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathogenesis </strong>– Staphylococcus-associated glomerulonephritis is an immune complex-mediated kidney disease in which the antigen component of the immune complex is derived from the infective agent, similar to poststreptococcal glomerulonephritis. The details of the pathogenesis of staphylococcus-associated glomerulonephritis are not entirely clear. (See <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations </strong>– Adults with staphylococcus-associated glomerulonephritis usually present with a <strong>concurrent infection</strong> and frequently with hematuria, proteinuria of varying degrees, a rising serum creatinine, and/or edema. Cutaneous vasculitis can occur, imitating immunoglobulin A (IgA) vasculitis or antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis. The majority of patients will have hypocomplementemia (usually with a low C3). An inciting staphylococcal infection can be identified from a positive culture. In some patients, an infectious agent cannot be identified, and suspicion of staphylococcus-associated glomerulonephritis is based upon a probable infection. (See <a class="local">'Clinical manifestations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis </strong>– The presence of staphylococcus-associated glomerulonephritis should be suspected in patients with clinical manifestations of active glomerulonephritis (eg, hematuria with or without red cell casts, often accompanied by proteinuria and an elevation in serum creatinine) in conjunction with a known or suspected recent or concurrent staphylococcal infection. (See <a class="local">'When to suspect the diagnosis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In patients with suspected staphylococcus-associated glomerulonephritis, we perform serologic testing to evaluate for other potential causes of glomerulonephritis. A kidney biopsy may be required to make the diagnosis. (See <a class="local">'Diagnostic evaluation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A <strong>presumptive </strong>diagnosis of staphylococcus-associated glomerulonephritis can be made if <strong>at least two</strong> of the following criteria are satisfied in a patient with evidence of <em>Staphylococcus</em> infection concurrent with the onset of glomerulonephritis:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Hypocomplementemia (primarily low C3)</p><p class="bulletIndent3"><span class="glyph">-</span>Endocapillary proliferation and exudative glomerulonephritis on light microscopy  (<a class="graphic graphic_picture graphicRef51688" href="/d/graphic/51688.html" rel="external">picture 4</a>)</p><p class="bulletIndent3"><span class="glyph">-</span>C3 dominant or codominant glomerular staining on immunofluorescence microscopy  (<a class="graphic graphic_picture graphicRef63432" href="/d/graphic/63432.html" rel="external">picture 1</a>)</p><p class="bulletIndent3"><span class="glyph">-</span>Hump-shaped subepithelial deposits on electron microscopy  (<a class="graphic graphic_picture graphicRef76739" href="/d/graphic/76739.html" rel="external">picture 3</a>)</p><p></p><p class="bulletIndent2">However, hypocomplementemia and these pathologic findings are <strong>not</strong> completely specific for glomerulonephritis due to a bacterial infection. Thus, a <strong>confirmed</strong> diagnosis of staphylococcus-associated glomerulonephritis requires that the disease activity (eg, hematuria, hypocomplementemia if present) abate after successful eradication of the infection, although there may be persistent elevation of the serum creatinine and proteinuria reflecting irreversible kidney injury. (See <a class="local">'Establishing the diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment </strong>– Treatment of staphylococcus-associated glomerulonephritis in adults should focus on eradicating the infection, relieving symptoms, and controlling hypertension and edema. We do <strong>not</strong> use immunosuppressive therapy in such patients. (See <a class="local">'Treatment'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical course </strong>– In adults with staphylococcus-associated glomerulonephritis, successful eradication of the infection should result in resolution of the glomerulonephritis. This resolution is usually manifest by stabilization of the serum creatinine, disappearance of hematuria, and normalization of complement levels, a process that may take months. However, many patients with staphylococcus-associated glomerulonephritis do not have complete resolution of the serum creatinine to their prior baseline and will also have persistent proteinuria. (See <a class="local">'Monitoring the clinical course'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Satoskar AA, Parikh SV, Nadasdy T. Epidemiology, pathogenesis, treatment and outcomes of infection-associated glomerulonephritis. Nat Rev Nephrol 2020; 16:32.</a></li><li><a class="nounderline abstract_t">Satoskar AA, Suleiman S, Ayoub I, et al. Staphylococcus Infection-Associated GN - Spectrum of IgA Staining and Prevalence of ANCA in a Single-Center Cohort. Clin J Am Soc Nephrol 2017; 12:39.</a></li><li><a class="nounderline abstract_t">Nasr SH, D'Agati VD. IgA-dominant postinfectious glomerulonephritis: a new twist on an old disease. Nephron Clin Pract 2011; 119:c18.</a></li><li><a class="nounderline abstract_t">Nasr SH, Markowitz GS, Whelan JD, et al. IgA-dominant acute poststaphylococcal glomerulonephritis complicating diabetic nephropathy. Hum Pathol 2003; 34:1235.</a></li><li><a class="nounderline abstract_t">Nadasdy T, Hebert LA. Infection-related glomerulonephritis: understanding mechanisms. Semin Nephrol 2011; 31:369.</a></li><li><a class="nounderline abstract_t">Nasr SH, Radhakrishnan J, D'Agati VD. Bacterial infection-related glomerulonephritis in adults. Kidney Int 2013; 83:792.</a></li><li><a class="nounderline abstract_t">Yousif Y, Okada K, Batsford S, Vogt A. Induction of glomerulonephritis in rats with staphylococcal phosphatase: new aspects in post-infectious ICGN. Kidney Int 1996; 50:290.</a></li><li><a class="nounderline abstract_t">Fujigaki Y, Yousif Y, Morioka T, et al. Glomerular injury induced by cationic 70-kD staphylococcal protein; specific immune response is not involved in early phase in rats. J Pathol 1998; 184:436.</a></li><li><a class="nounderline abstract_t">Koyama A, Sharmin S, Sakurai H, et al. Staphylococcus aureus cell envelope antigen is a new candidate for the induction of IgA nephropathy. Kidney Int 2004; 66:121.</a></li><li><a class="nounderline abstract_t">Koyama A, Kobayashi M, Yamaguchi N, et al. Glomerulonephritis associated with MRSA infection: a possible role of bacterial superantigen. Kidney Int 1995; 47:207.</a></li><li><a class="nounderline abstract_t">Sharmin S, Shimizu Y, Hagiwara M, et al. Staphylococcus aureus antigens induce IgA-type glomerulonephritis in Balb/c mice. J Nephrol 2004; 17:504.</a></li><li><a class="nounderline abstract_t">Shimizu Y, Sakurai H, Hirayama K, et al. Staphylococcal cell membrane antigen, a possible antigen in post-methicillin resistant Staphylococcus aureus (MRSA) infection nephritis and IgA nephropathy, exhibits high immunogenic activity that is enhanced by superantigen. J Nephrol 2005; 18:249.</a></li><li><a class="nounderline abstract_t">Nasr SH, Markowitz GS, Stokes MB, et al. Acute postinfectious glomerulonephritis in the modern era: experience with 86 adults and review of the literature. Medicine (Baltimore) 2008; 87:21.</a></li><li><a class="nounderline abstract_t">Montseny JJ, Meyrier A, Kleinknecht D, Callard P. The current spectrum of infectious glomerulonephritis. Experience with 76 patients and review of the literature. Medicine (Baltimore) 1995; 74:63.</a></li><li><a class="nounderline abstract_t">Nasr SH, Fidler ME, Valeri AM, et al. Postinfectious glomerulonephritis in the elderly. J Am Soc Nephrol 2011; 22:187.</a></li><li><a class="nounderline abstract_t">Wen YK, Chen ML. The significance of atypical morphology in the changes of spectrum of postinfectious glomerulonephritis. Clin Nephrol 2010; 73:173.</a></li><li><a class="nounderline abstract_t">Moroni G, Pozzi C, Quaglini S, et al. Long-term prognosis of diffuse proliferative glomerulonephritis associated with infection in adults. Nephrol Dial Transplant 2002; 17:1204.</a></li><li><a class="nounderline abstract_t">John EE, Thomas A, Eapen JJ, et al. Latency, Anti-Bacterial Resistance Pattern, and Bacterial Infection-Related Glomerulonephritis. Clin J Am Soc Nephrol 2021; 16:1210.</a></li><li><a class="nounderline abstract_t">Glassock RJ. Glomerular disease in the elderly. Clin Geriatr Med 2009; 25:413.</a></li><li><a class="nounderline abstract_t">Satoskar AA, Nadasdy G, Plaza JA, et al. Staphylococcus infection-associated glomerulonephritis mimicking IgA nephropathy. Clin J Am Soc Nephrol 2006; 1:1179.</a></li><li><a class="nounderline abstract_t">Satoskar AA, Molenda M, Scipio P, et al. Henoch-Schönlein purpura-like presentation in IgA-dominant Staphylococcus infection - associated glomerulonephritis - a diagnostic pitfall. Clin Nephrol 2013; 79:302.</a></li><li><a class="nounderline abstract_t">Boils CL, Nasr SH, Walker PD, et al. Update on endocarditis-associated glomerulonephritis. Kidney Int 2015; 87:1241.</a></li><li><a class="nounderline abstract_t">Ooi JD, Jiang JH, Eggenhuizen PJ, et al. A plasmid-encoded peptide from Staphylococcus aureus induces anti-myeloperoxidase nephritogenic autoimmunity. Nat Commun 2019; 10:3392.</a></li><li><a class="nounderline abstract_t">Haffner D, Schindera F, Aschoff A, et al. The clinical spectrum of shunt nephritis. Nephrol Dial Transplant 1997; 12:1143.</a></li><li><a class="nounderline abstract_t">Miquelestorena-Standley E, Jaulerry C, Machet MC, et al. Clinicopathologic features of infection-related glomerulonephritis with IgA deposits: a French Nationwide study. Diagn Pathol 2020; 15:62.</a></li><li><a class="nounderline abstract_t">Choi HK, Lamprecht P, Niles JL, et al. Subacute bacterial endocarditis with positive cytoplasmic antineutrophil cytoplasmic antibodies and anti-proteinase 3 antibodies. Arthritis Rheum 2000; 43:226.</a></li><li><a class="nounderline abstract_t">Majumdar A, Chowdhary S, Ferreira MA, et al. Renal pathological findings in infective endocarditis. Nephrol Dial Transplant 2000; 15:1782.</a></li><li><a class="nounderline abstract_t">Vella J, Carmody M, Campbell E, et al. Glomerulonephritis after ventriculo-atrial shunt. QJM 1995; 88:911.</a></li><li><a class="nounderline abstract_t">Kiryluk K, Preddie D, D'Agati VD, Isom R. A young man with Propionibacterium acnes-induced shunt nephritis. Kidney Int 2008; 73:1434.</a></li><li><a class="nounderline abstract_t">Sorger K, Gessler M, Hübner FK, et al. Follow-up studies of three subtypes of acute postinfectious glomerulonephritis ascertained by renal biopsy. Clin Nephrol 1987; 27:111.</a></li><li><a class="nounderline abstract_t">Nagaba Y, Hiki Y, Aoyama T, et al. Effective antibiotic treatment of methicillin-resistant Staphylococcus aureus-associated glomerulonephritis. Nephron 2002; 92:297.</a></li><li><a class="nounderline abstract_t">Worawichawong S, Girard L, Trpkov K, et al. Immunoglobulin A-dominant postinfectious glomerulonephritis: frequent occurrence in nondiabetic patients with Staphylococcus aureus infection. Hum Pathol 2011; 42:279.</a></li><li><a class="nounderline abstract_t">Gale DP, de Jorge EG, Cook HT, et al. Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis. Lancet 2010; 376:794.</a></li><li><a class="nounderline abstract_t">Brodsky SV, Nadasdy T, Cassol C, Satoskar A. IgA Staining Patterns Differentiate Between IgA Nephropathy and IgA-Dominant Infection-Associated Glomerulonephritis. Kidney Int Rep 2020; 5:909.</a></li><li><a class="nounderline abstract_t">Hirayama K, Kobayashi M, Kondoh M, et al. Henoch-Schönlein purpura nephritis associated with methicillin-resistant Staphylococcus aureus infection. Nephrol Dial Transplant 1998; 13:2703.</a></li><li><a class="nounderline abstract_t">Eftychiou C, Samarkos M, Golfinopoulou S, et al. Henoch-Schonlein purpura associated with methicillin-resistant Staphylococcus aureus infection. Am J Med 2006; 119:85.</a></li><li><a class="nounderline abstract_t">Satoskar AA, Shapiro JP, Jones M, et al. Differentiating Staphylococcus infection-associated glomerulonephritis and primary IgA nephropathy: a mass spectrometry-based exploratory study. Sci Rep 2020; 10:17179.</a></li><li><a class="nounderline abstract_t">Grosser DS, Persad P, Talento RV, et al. IgA-dominant infection-associated glomerulonephritis in the pediatric population. Pediatr Nephrol 2022; 37:593.</a></li><li><a class="nounderline abstract_t">Rovin BH, Tang Y, Sun J, et al. Clinical significance of fever in the systemic lupus erythematosus patient receiving steroid therapy. Kidney Int 2005; 68:747.</a></li><li><a class="nounderline abstract_t">Agarwal A, Clements J, Sedmak DD, et al. Subacute bacterial endocarditis masquerading as type III essential mixed cryoglobulinemia. J Am Soc Nephrol 1997; 8:1971.</a></li><li><a class="nounderline abstract_t">Glassock RJ, Alvarado A, Prosek J, et al. Staphylococcus-related glomerulonephritis and poststreptococcal glomerulonephritis: why defining "post" is important in understanding and treating infection-related glomerulonephritis. Am J Kidney Dis 2015; 65:826.</a></li><li><a class="nounderline abstract_t">Wang SY, Bu R, Zhang Q, et al. Clinical, Pathological, and Prognostic Characteristics of Glomerulonephritis Related to Staphylococcal Infection. Medicine (Baltimore) 2016; 95:e3386.</a></li></ol></div><div id="topicVersionRevision">Topic 86317 Version 17.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31399725" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Epidemiology, pathogenesis, treatment and outcomes of infection-associated glomerulonephritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27821389" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Staphylococcus Infection-Associated GN - Spectrum of IgA Staining and Prevalence of ANCA in a Single-Center Cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21659781" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : IgA-dominant postinfectious glomerulonephritis: a new twist on an old disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14691907" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : IgA-dominant acute poststaphylococcal glomerulonephritis complicating diabetic nephropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21839370" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Infection-related glomerulonephritis: understanding mechanisms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23302723" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Bacterial infection-related glomerulonephritis in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8807600" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Induction of glomerulonephritis in rats with staphylococcal phosphatase: new aspects in post-infectious ICGN.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9664912" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Glomerular injury induced by cationic 70-kD staphylococcal protein; specific immune response is not involved in early phase in rats.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15200419" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Staphylococcus aureus cell envelope antigen is a new candidate for the induction of IgA nephropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7731148" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Glomerulonephritis associated with MRSA infection: a possible role of bacterial superantigen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15372411" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Staphylococcus aureus antigens induce IgA-type glomerulonephritis in Balb/c mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16013011" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Staphylococcal cell membrane antigen, a possible antigen in post-methicillin resistant Staphylococcus aureus (MRSA) infection nephritis and IgA nephropathy, exhibits high immunogenic activity that is enhanced by superantigen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18204367" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Acute postinfectious glomerulonephritis in the modern era: experience with 86 adults and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7891544" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : The current spectrum of infectious glomerulonephritis. Experience with 76 patients and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21051737" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Postinfectious glomerulonephritis in the elderly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20178715" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : The significance of atypical morphology in the changes of spectrum of postinfectious glomerulonephritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12105242" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Long-term prognosis of diffuse proliferative glomerulonephritis associated with infection in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34099500" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Latency, Anti-Bacterial Resistance Pattern, and Bacterial Infection-Related Glomerulonephritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19765489" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Glomerular disease in the elderly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17699345" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Staphylococcus infection-associated glomerulonephritis mimicking IgA nephropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23320971" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Henoch-Schönlein purpura-like presentation in IgA-dominant Staphylococcus infection - associated glomerulonephritis - a diagnostic pitfall.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25607109" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Update on endocarditis-associated glomerulonephritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31358739" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : A plasmid-encoded peptide from Staphylococcus aureus induces anti-myeloperoxidase nephritogenic autoimmunity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9198042" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : The clinical spectrum of shunt nephritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32460869" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Clinicopathologic features of infection-related glomerulonephritis with IgA deposits: a French Nationwide study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10643719" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Subacute bacterial endocarditis with positive cytoplasmic antineutrophil cytoplasmic antibodies and anti-proteinase 3 antibodies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11071965" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Renal pathological findings in infective endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8593552" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Glomerulonephritis after ventriculo-atrial shunt.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18322539" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : A young man with Propionibacterium acnes-induced shunt nephritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3552342" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Follow-up studies of three subtypes of acute postinfectious glomerulonephritis ascertained by renal biopsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12218306" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Effective antibiotic treatment of methicillin-resistant Staphylococcus aureus-associated glomerulonephritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21111456" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Immunoglobulin A-dominant postinfectious glomerulonephritis: frequent occurrence in nondiabetic patients with Staphylococcus aureus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20800271" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32518872" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : IgA Staining Patterns Differentiate Between IgA Nephropathy and IgA-Dominant Infection-Associated Glomerulonephritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9794595" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Henoch-Schönlein purpura nephritis associated with methicillin-resistant Staphylococcus aureus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16431201" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Henoch-Schonlein purpura associated with methicillin-resistant Staphylococcus aureus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33057112" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Differentiating Staphylococcus infection-associated glomerulonephritis and primary IgA nephropathy: a mass spectrometry-based exploratory study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34453602" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : IgA-dominant infection-associated glomerulonephritis in the pediatric population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16014052" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Clinical significance of fever in the systemic lupus erythematosus patient receiving steroid therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9402102" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Subacute bacterial endocarditis masquerading as type III essential mixed cryoglobulinemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25890425" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Staphylococcus-related glomerulonephritis and poststreptococcal glomerulonephritis: why defining "post" is important in understanding and treating infection-related glomerulonephritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27082609" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Clinical, Pathological, and Prognostic Characteristics of Glomerulonephritis Related to Staphylococcal Infection.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
